Medical Journals

Estradiol-17beta Stimulates Proliferation of Mouse Embryonic Stem Cells: Involvement of Mapks and Cdks As Well As Protooncogenes.

Authors:
  • Han Ho Jae
  • Heo Jung Sun
  • Lee Yun Jung

From: Department of Veterinary Physiology, College of Veterinary Medicine, Chonnam National University, Gwangju 500-757, Korea. hjhan@chonnam.ac.kr

American journal of physiology. Cell physiology

  • Publish Date: Apr 2006
  • ISSN: 0363-6143
  • Volume: 290
  • Issue: 4
  • Pages: C1067-75
  • Medium: Print
  • Language: English
  • Citation (JAMA): Han Ho Jae, Heo Jung Sun, Lee Yun Jung, et al. Estradiol-17beta Stimulates Proliferation of Mouse Embryonic Stem Cells: Involvement of Mapks and Cdks As Well As Protooncogenes.. Am. J. Physiol., Cell Physiol. Apr 2006;290:C1067-75

Abstract

Although the importance of estradiol-17beta (E(2)) in many physiological processes has been reported, to date no researchers have investigated the effects of E(2) on embryonic stem (ES) cell proliferation. Therefore, in the present study, we have examined the effect of E(2) on the DNA synthesis of murine ES (ES-E14TG2a) cells and its related signaling pathways. The results of this study show that E(2) (10(-9) M) significantly increased [(3)H]thymidine incorporation at >4 h and that E(2) (>10(-12) M) induced an increase of [(3)H]thymidine incorporation after 8-h incubation. Moreover, E(2) (>10(-12) M) also increased 5’-bromo-2’-deoxyuridine (BrdU) incorporation and cell number. Indeed, E(2) stimulated estrogen receptor (ER)-alpha and -beta protein levels and increased mRNA expression levels of protooncogenes (c-fos, c-jun, and c-myc). Tamoxifen (antiestrogen) completely inhibited E(2)-induced increases in [(3)H]thymidine incorporation. In addition, estradiol-6-O-carboxymethyl oxime-BSA (E(2)-BSA; 10(-9) M) increased [(3)H]thymidine incorporation at >1 h, and E(2)-BSA (>10(-12) M) increased [(3)H]thymidine incorporation after 1-h incubation. E(2)-BSA-induced increase in BrdU incorporation also occurred in a dose-dependent manner. Tamoxifen had no effect on E(2)-BSA-induced increase of [(3)H]thymidine incorporation. Also, E(2) and E(2)-BSA displayed maximal phosphorylation of p44/42 MAPKs at 10 and 5 min, respectively. E(2) increased cyclins D1 and E as well as cyclin-dependent kinase (CDK)2 and CDK4. In contrast, E(2) decreased the levels of p21(cip1) and p27(kip1) (CDK-inhibitory proteins). Increases of these cell cycle regulators were blocked by 10(-5) M PD-98059 (MEK inhibitor). Moreover, E(2)-induced increase of [(3)H]thymidine incorporation was inhibited by PD-98059 or butyrolactone I (CDK2 inhibitor). In conclusion, estradiol-17beta stimulates the proliferation of murine ES cells, and this action is mediated by MAPKs, CDKs, or protooncogenes.

Mesh Headings (Keywords): Animals, Cell Proliferation, Cells, Cultured, Cyclin-Dependent Kinases, Estradiol, Estrogen Antagonists, Estrogen Receptor alpha, Estrogen Receptor beta, Mice, Mitogen-Activated Protein Kinases, Proto-Oncogenes, Signal Transduction, Stem Cells, Tamoxifen, Thymidine


Check for Full Text / PubMed Unique Identifier (PMID): 16291822


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.